
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $626.6M | -- | -- | $0.41 | -- |
07/25/2025 | Q2 | $602.6M | -- | -- | $0.38 | -- |
04/25/2025 | Q1 | $572.1M | $576.8M | $0.42 | $0.42 | $0.00 |
01/31/2025 | Q4 | $600.5M | $541.6M | $0.39 | $0.49 | -$0.10 |
10/25/2024 | Q3 | $588M | $608.5M | $0.53 | $0.47 | $0.06 |
07/26/2024 | Q2 | $618M | $572.9M | $0.37 | $0.51 | -$0.14 |
04/26/2024 | Q1 | $599M | $590.2M | $0.47 | $0.47 | -$0.00 |
01/26/2024 | Q4 | $562.2M | $589.1M | $0.50 | $0.44 | $0.06 |
10/27/2023 | Q3 | -- | -- | $0.45 | $0.43 | $0.02 |
07/28/2023 | Q2 | -- | -- | $0.47 | $0.41 | $0.06 |
04/28/2023 | Q1 | -- | -- | $0.42 | $0.37 | $0.05 |
01/27/2023 | Q4 | -- | -- | $0.37 | $0.39 | -$0.02 |
10/28/2022 | Q3 | -- | -- | $0.31 | $0.38 | -$0.07 |
07/22/2022 | Q2 | -- | -- | $0.31 | $0.38 | -$0.07 |
04/22/2022 | Q1 | -- | -- | $0.37 | $0.32 | $0.05 |
01/28/2022 | Q4 | -- | -- | $0.35 | $0.35 | $0.00 |
10/22/2021 | Q3 | -- | -- | $0.32 | $0.36 | -$0.04 |
07/23/2021 | Q2 | -- | -- | $0.36 | $0.43 | -$0.07 |
04/23/2021 | Q1 | -- | -- | $0.46 | $0.49 | -$0.03 |
01/29/2021 | Q4 | -- | -- | $0.58 | $0.50 | $0.08 |
10/23/2020 | Q3 | -- | -- | $0.48 | $0.41 | $0.07 |
07/24/2020 | Q2 | -- | -- | -$0.01 | $0.13 | -$0.14 |
04/24/2020 | Q1 | -- | -- | $0.36 | $0.35 | $0.01 |
01/31/2020 | Q4 | -- | -- | $0.39 | $0.37 | $0.02 |
10/18/2019 | Q3 | -- | -- | $0.44 | $0.42 | $0.02 |
07/19/2019 | Q2 | -- | -- | $0.42 | $0.40 | $0.02 |
04/24/2019 | Q1 | -- | -- | $0.40 | $0.39 | $0.01 |
01/30/2019 | Q4 | -- | -- | $0.41 | $0.44 | -$0.03 |
10/19/2018 | Q3 | -- | -- | $0.42 | $0.41 | $0.01 |
07/20/2018 | Q2 | -- | -- | $0.40 | -- | -- |
04/20/2018 | Q1 | -- | -- | $0.40 | -- | -- |
01/26/2018 | Q4 | -- | -- | $0.46 | -- | -- |
10/20/2017 | Q3 | -- | -- | $0.31 | -- | -- |
07/21/2017 | Q2 | -- | -- | $0.31 | -- | -- |
04/21/2017 | Q1 | -- | -- | $0.33 | -- | -- |
01/27/2017 | Q4 | -- | -- | $0.31 | -- | -- |
10/20/2016 | Q3 | -- | -- | $0.32 | -- | -- |
07/22/2016 | Q2 | -- | -- | $0.30 | -- | -- |
04/22/2016 | Q1 | -- | -- | $0.28 | -- | -- |
01/28/2016 | Q4 | -- | -- | $0.30 | -- | -- |
10/21/2015 | Q3 | -- | -- | $0.27 | -- | -- |
Gentex reported $576.8M worth of top line sales in its most recent quarter.
Gentex announced earnings per share of $0.42 which represents a beat of analyst forecast a $0.42 per share.
Gentex reported $191.7M that represents $0.86 per share over the last quarter.
Gentex's earnings are forecast to decrease from $1.76 per share to $1.87 per share next year representing a decrease of -5.25%.
Gentex's next earnings date is July 25, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.